Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ABCL - AbCellera teams up with EQRx in new innovative medicines

ABCL - AbCellera teams up with EQRx in new innovative medicines

AbCellera Biologics Inc.
AbCellera (NASDAQ:ABCL) perks up 3.4% premarket after announcing collaboration agreement with EQRx for the discovery and development of therapeutic antibodies. The collaboration will leverage AbCellera’s AI-powered antibody discovery technology to search and analyze natural immune responses to identify novel antibody drug candidates for multiple targets. The deal also includes the option for additional investment from AbCellera at progressive stages of product development and commercialization in exchange for an increased share of product sales. The initial programs will focus on targets in oncology and immunology.

For further details see:

AbCellera teams up with EQRx in new innovative medicines
Stock Information
Company Name: AbCellera Biologics Inc.
Stock Symbol: ABCL
Market: NASDAQ
Website: abcellera.com
Menu
ABCL ABCL Quote ABCL Short ABCL News ABCL Articles ABCL Message Board
Get ABCL Alerts

News, Short Squeeze, Breakout and More Instantly...